RIDGEBACK CAPITAL MANAGEMENT

Size: px
Start display at page:

Download "RIDGEBACK CAPITAL MANAGEMENT"

Transcription

1 Firm: RIDGEBACK CAPITAL MANAGEMENT RIDGEBACK CAPITAL MANAGEMENT Asset Manager Headcount: Hidden Founded in Hidden Assets Under Management: Hidden Hidden Hidden Hidden SEC Enforcement: Balmy Belize No Refuge for Stock Scammers The 10 investment firms named in connection with beneficial ownership were: Brown Brothers Harriman & Co.; Del Mar Asset Management LP; Lazarus Management Company LLC; P.A.W. Capital Partners LP; Ridgeback Capital Management LP; RIMA Senvest Management LLC... Think Advisor September 12, 2014 Company Overview of Ridgeback Capital Management, LLC Ridgeback Capital Management LLC (RCM) is an employee owned investment manager. The firm invests in the public equity markets of the United States. Ridgeback Capital Management is based in New York, New York. Bloomberg June 30, 2015 Wayne Holman s Hedge Fund Takes 5.8% Stake in Geron Wayne Holman, Geron Corporation: This morning, Wayne Holman s hedge fund Ridgeback Capital Management reported adding Geron Corporation (NASDAQ:GERN) to its equity portfolio through purchasing a passive stake that represents 5.8% of the company. INSIDER MONKEY October 17, 2013

2 Form 6-K Prima BioMed Ltd For: May 29 Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20- F or Form 40-F. Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the... StreetInsider May 29, 2015 SEC targets late filers The investment firms that were charged included Brown Brothers Harriman, The Royal Bank of Scotland and Ridgeback Capital Management. The companies that were fined included Starwood Hotel & Resorts, Universal Electronics and Willis Lease Finance. Inside Counsel September 11, 2014 Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing Eleven new investors participated in the round, including funds managed by RA Capital Management, LLC, Perceptive Advisors, LLC, Jennison Associates LLC (on behalf of certain clients), Sabby Capital, LLC, Ridgeback Capital Management, venbio Select... Business Wire August 27, 2014 In A Quiet Week For IPOs, Bellicum Pharmaceuticals Stands Out Ridgeback Capital Management, venbio Select, Redmile Group, AJU IB Investment, and others. All of the big current investors, including AVG Ventures and Remeditex Ventures, also joined in. While the scientific and medical prospects for Bellicum's CID... Seeking Alpha December 17, 2014

3 Adaptimmune raises $104 million to develop immune-system cancer drugs Adaptimmune's funding round was led by New Enterprise Associates. Additional new investors included OrbiMed Advisors, Wellington Management Company, Fidelity Biosciences, Foresite Capital Management, Ridgeback Capital Management, Novo A/S, QVT, Rock... Reuters September 24, 2014 Grabbing a quick $55M venture round, Bellicum Pharma ponders an IPO Ridgeback Capital Management, venbio Select, Redmile Group, AJU IB Investment and others. All of the big current investors, including AVG Ventures and Remeditex Ventures, also joined in. Bellicum has now raised a total of $107 million, says Farrell... Fierce Biotech August 27, 2014 Ex-SAC Trader Seeks to Use Cohen Testimony SAC Capital also invested money with Mr. Holman s fund, Ridgeback Capital Management, and Mr. Holman had a consulting... I was bullish based on the recommendation of Mat Martoma and Wayne Holman. And there may have been others that were bullish; I... Deal Book December 7, 2013 Trial to focus on trades by SAC's Cohen In the deposition, Cohen told investigators he decided to sell Wyeth securities after talking to Wayne Holman, a former SAC trader who went on to establish his own hedge fund, Ridgeback Capital Management. A lawyer for Holman did not respond to a request...

4 Yahoo Finance January 6, 2014 U.S. rests its case in insider trading trial of SAC's Martoma The former portfolio, Wayne Holman, had left SAC Capital in 2006 and started up his own hedge fund, Ridgeback Capital Management. SAC Capital entered into a deal with Holman to advise on investing in Wyeth in November 2007, Nussbaum said. "He was expected... KFGO January 28, 2014 Adaptimmune engineers $104m Joining the company s existing investors are OrbiMed Advisors, Wellington Management Company, Fidelity Biosciences, Foresite Capital Management, Ridgeback Capital Management, Novo A/S, QVT, Rock Springs Capital, venbio Select and Merlin Nexus. globaluniversityventuring.com September 26, 2014 Wayne Holman Mr. Wayne Holman is currently employed at Ridgeback Capital Management LLC. He is a managing member at the firm. Mr. Holman also serves as a Director at Ridgeback Capital Investments Ltd. To contact Ridgeback Capital Management, LLC, please visit Bloomberg August 1, 2015 Defense Plays Down Martoma's Role During testimony that lasted less than an hour over two days, Mr. Nussbaum confirmed that SAC had a contract with Wayne Holman, a former SAC employee who left to start hedge fund Ridgeback

5 Capital Management LLC, to advise Mr. Cohen on Wyeth. According to... Wall Street Journal January 29, 2014 Biotech firm developing new cancer treatments raises $104M Adaptimmune Ltd., a biotechnology company with offices in Oxford... Foresite Capital Management, Ridgeback Capital Management, Novo A/S, QVT, Rock Springs Capital, venbio Select and Merlin Nexus. Adaptimmune plans to use the proceeds from the stock... The Business Journal September 29, 2014 Adaptimmune raises $104 mln to develop immune-system cancer drugs Adaptimmune's funding round was led by New Enterprise Associates. Additional new investors included OrbiMed Advisors, Wellington Management Company, Fidelity Biosciences, Foresite Capital Management, Ridgeback Capital Management, Novo A/S, QVT, Rock... Reuters September 24, 2014 SAC's Cohen told SEC hedge fund friend advised Wyeth share sale "We're good friends," Cohen, who hasn't been charged with wrongdoing, said of Wayne Holman, a former SAC employee who left and started Ridgeback Capital Management. "We go to dinner. The wives are friendly. You know, we see each other off and on." Connecticut Post December 10, 2013 U.S. rests its case in insider trading trial of SAC's Martoma

6 The former portfolio, Wayne Holman, had left SAC Capital in 2006 and started up his own hedge fund, Ridgeback Capital Management. SAC Capital entered into a deal with Holman to advise on investing in Wyeth in November 2007, Nussbaum said. "He was expected... Yahoo News January 29, 2014 Key Executives for Ridgeback Capital Management, LLC To contact Ridgeback Capital Management, LLC, please visit. Company data is provided by Capital IQ. Please use this form to report any data issues. Bloomberg July 28, 2015 Steve Cohen Would Never Have Listened To Mathew Martoma s Advice About Stocks: Mathew Martoma s Lawyers But Martoma s lawyers would like his testimony from last... Holman, who ran the defunct Ridgeback Capital Management, had a $20 million consulting deal, and Cohen said that the week SAC sold Wyeth, Holman was telling me he was selling his Wyeth. Dealbreaker December 9, 2013 Investment in Watertown s Selecta hints at growing interest from Genzyme, Sanofi Other investors in the $38 million round being announced today include OrbiMed, an institutional healthcare investor that was has already taken part in previous rounds for Selecta, and new investors Ridgeback Capital Management, Osage Partners, Aju IB... The Business Journal September 8, 2015 Selecta chooses Sanofi for $38m series E

7 Investment firm OrbiMed led the round, which also featured Ridgeback Capital Management, Osage University Partners, AJU IB Investment, Sphera Global Health Care Fund and all Selecta s existing investors, which include Rusnano, Flagship Ventures... globaluniversityventuring.com September 11, 2015 Selecta Announces $38 Million Series E Financing The largest investor in this Series E round is OrbiMed, a leading institutional healthcare investor, and includes new investors, Sanofi-Genzyme BioVentures, Ridgeback Capital Management, Osage University Partners, AJU IB Investment and Sphera Global Health... Business Wire September 8, 2015 Selecta, Eyeing IPO, Brings Sanofi, Crossovers Aboard For $38M Round Selecta has added a group of new backers in this latest round, among them the VC arm of Sanofi (Sanofi-Genzyme Bioventures), and several crossover investors including OrbiMed, Ridgeback Capital Management, and Osage Partners. The company s existing... Xconomy September 8, 2015 Star Island manse spared wrecking ball for now Wayne Holman, founder of Ridgeback Capital Management, and his wife Wendy, formerly of Ziff Brothers Investments, bought the house and the 60,735-square-foot lot from Sam and Roni Jacobson for $18.8 million in June 2014 because of its lush landscaping and... The Real Deal September 1, 2015

8 Adaptimmune gathers $104M to fuel hot immuno-oncology tech race Back at the beginning of June, Adaptimmune only had about a million pounds sterling... Foresite Capital Management, Ridgeback Capital Management, Novo A/S, QVT, Rock Springs Capital, venbio Select and Merlin Nexus adding their own investments. Fierce Biotech September 24, 2014 Adaptimmune raises $104 million to develop immune-system cancer drugs Ridgeback Capital Management, Novo A/S, QVT, Rock Springs Capital, venbio Select and Merlin Nexus. (ing by Ben Hirschler; Editing by David Goodman) Disease & Medical Conditions Health cancer drugs immune system ovarian cancer Yahoo News September 24, 2014 Steve Cohen's perpetual divorce puts insider claims center stage Steven Cohen was previously questioned about the trades. He told the SEC in 2012 that he sold Wyeth stock after learning that Ridgeback Capital Management LLC founder Wayne Holman was doing so, according to U.S. District Judge Paul Gardephe, who presided... Daily Herald November 24, 2014 Star Island manse to be demolished, replaced by modern home Wayne Holman, founder of Ridgeback Capital Management and his wife Wendy, formerly of Ziff Brothers Investments, bought the house and the 60,735-square-foot lot from Sam and Roni Jacobson for $18.8 million in June The property is adjacent to a... The Real Deal November 30, 2015

9 Ex-SAC Trader Cites Cohen As Trial Approaches Holman, who ran the defunct Ridgeback Capital Management, had a $20 million consulting deal, and Cohen said that the week SAC sold Wyeth, Holman "was telling me he was selling his Wyeth." Cohen said he judged Holman to be "one of the great healthcare... FIN Alternatives December 9, 2013 Bellicum Pharmaceuticals Gets $55M For Immunotherapy Efforts According to Bellicum, the funding came from RA Capital Management, LLC, Perceptive Advisors, LLC, Jennison Associates LLC (on behalf of certain clients), Sabby Capital, LLC, Ridgeback Capital Management, venbio Select, Redmile Group, LLC, AJU IB... Texas Tech Pulse August 27, 2014 No news for RIDGEBACK CAPITAL MANAGEMENT right now. Check back soon! Powered by DISCLAIMERS

Waratah Capital Advisors

Waratah Capital Advisors Firm: Waratah Capital Advisors Waratah Capital Advisors Asset Manager Headcount: Hidden Founded in Hidden Assets Under Management: Hidden Hidden Hidden Hidden Waratah Capital Advisors Ltd. Best Relative

More information

AMERRA CAPITAL MANAGEMENT, LLC

AMERRA CAPITAL MANAGEMENT, LLC Firm: AMERRA CAPITAL MANAGEMENT, LLC AMERRA CAPITAL MANAGEMENT, LLC Asset Manager Founded in Hidden Hidden Hidden Hidden Headcount: Hidden Assets Under Management: Hidden Umami Sustainable Seafood Enters

More information

REYL and CIE, Samena Capital form cross-border asset management JV

REYL and CIE, Samena Capital form cross-border asset management JV Firm: Samena Asia Managers Samena Asia Managers Evaluator Julius Wang Founded in Hidden Hidden Hidden Hidden Headcount: Hidden Assets Under Management: Hidden Mr. Julius Wang serves as Senior Managing

More information

Plaisance Capital. David Decker leaves Janus. Kozlowski engineers turnaround at Janus Contrarian Fund

Plaisance Capital. David Decker leaves Janus. Kozlowski engineers turnaround at Janus Contrarian Fund Firm: Plaisance Capital Plaisance Capital Asset Founded in Janus Contrarian T (JSVAX) Headcount: Assets Under Management: From 2008 to 2011, Mr. Kozlowski founded and managed Plaisance Capital, LLC, which

More information

Brookside Capital Management, LLC

Brookside Capital Management, LLC Firm: Brookside Capital Management, LLC Brookside Capital Management, LLC Asset Manager Filing Details Founded in Hidden Hidden Hidden Hidden Headcount: Hidden Assets Under Management: Hidden Represents

More information

Rothschild & Cie Gestion

Rothschild & Cie Gestion Firm: Rothschild & Cie Gestion Rothschild & Cie Gestion Asset Manager Headcount: Hidden Founded in Hidden Assets Under Management: Hidden Hidden Hidden Hidden Rothschild Terminates Plans for Commodities

More information

Evaluation Associates, LLC

Evaluation Associates, LLC Firm: Evaluation Associates, LLC Evaluation Associates, LLC Evaluator Founded in Hidden Hidden Hidden Hidden Company Overview of Evaluation Associates LLC Headcount: Hidden Assets Under Management: Hidden

More information

GSA CAPITAL PARTNERS LLP

GSA CAPITAL PARTNERS LLP Firm: GSA CAPITAL PARTNERS LLP GSA CAPITAL PARTNERS LLP Asset Manager Founded in Hidden Hidden Hidden Hidden GSA CAPITAL PARTNERS LLP Headcount: Hidden Assets Under Management: Hidden 4:01PM ET - GlobeNewswire

More information

QUARTERLY SHAREHOLDER ANALYSIS FEBRUARY 2016

QUARTERLY SHAREHOLDER ANALYSIS FEBRUARY 2016 SMALL CAP BIOTECH QUARTERLY SHAREHOLDER ANALYSIS FEBRUARY 2016 Holders Overview CBAY US Equity Shareholder Overview Top Institutional Holders Institution Style City Recent Pos. % Inst Shs % Shs. Out. Δ

More information

The Funding Landscape for Small Biopharma Ventures,

The Funding Landscape for Small Biopharma Ventures, HEALTHCARE The Funding Landscape for Small Biopharma Ventures, 2010-2015 Trends, strategies and priorities By Gaurav Misra Gaurav Misra Gaurav Misra specializes in pharmaceutical licensing, valuations

More information

Celsion Corp. Cancer Medications, Insider Buying and Analysis

Celsion Corp. Cancer Medications, Insider Buying and Analysis Celsion Corp. Cancer Medications, Insider Buying and Analysis Celsion Corp. (NASDAQ: CLSN), is an oncology drug development company focused on developing a portfolio of innovative cancer treatments, including

More information

dms Management Ltd Don Seymour DMS Presents European Hedge Fund Award Headcount: Hidden Assets Under Management: Hidden

dms Management Ltd Don Seymour DMS Presents European Hedge Fund Award Headcount: Hidden Assets Under Management: Hidden Firm: dms Management Ltd dms Management Ltd Asset Manager Founded in Hidden Hidden Hidden Hidden Campbell Global Assets Fund Ltd SAC Headcount: Hidden Assets Under Management: Hidden The Board of Directors

More information

Testimony of Sherrill Neff, Quaker BioVentures for the Joint Economic Committee of Congress July 10, 2008

Testimony of Sherrill Neff, Quaker BioVentures for the Joint Economic Committee of Congress July 10, 2008 Testimony of Sherrill Neff, Quaker BioVentures for the Joint Economic Committee of Congress July 10, 2008 Introduction: Members of the Committee, good morning. My name is Sherrill Neff and I am a partner

More information

HOW TO INVEST LIKE A HEDGE FUND BILLIONAIRE 1

HOW TO INVEST LIKE A HEDGE FUND BILLIONAIRE 1 HEDGE FUND BILLIONAIRE 1 THE PAST SEVERAL YEARS SINCE THE ECONOMIC RECESSION OF 2008 HAVE BROUGHT ABOUT MANY CHANGES IN THE MARKET INCLUDING THE CLOSING OF FLAGSHIP FUNDS BY U.S.-BASED HEDGE FUNDS. Due

More information

IP Group plc Interim Report and Accounts For the six months to 30 June 2006

IP Group plc Interim Report and Accounts For the six months to 30 June 2006 2006 and Accounts For the six months to 30 June 2006 IP Group has had a very successful six month period, generating record first half profits and seeing significant progress throughout the Group s portfolio.

More information

QUARTERLY SHAREHOLDER ANALYSIS FEBRUARY 2016

QUARTERLY SHAREHOLDER ANALYSIS FEBRUARY 2016 MIDCAP BIOTECH COMPANY QUARTERLY SHAREHOLDER ANALYSIS FEBRUARY 2016 Holders Overview CBAY US Equity MidCap Biotech Company Shareholder Overview Top Institutional Holders Institution Style City Recent Pos.

More information

EASTSPRING INVESTMENTS (SINGAPORE) LIMITED

EASTSPRING INVESTMENTS (SINGAPORE) LIMITED Firm: EASTSPRING INVESTMENTS (SINGAPORE) LIMITED EASTSPRING INVESTMENTS (SINGAPORE) LIMITED Asset Manager Headcount: Hidden Founded in Hidden Assets Under Management: Hidden Hidden Hidden Hidden Key Executives

More information

McLean & Partners Wealth Management

McLean & Partners Wealth Management Firm: McLean & Partners Wealth Management McLean & Partners Wealth Management Evaluator Headcount: Hidden Founded in Hidden Assets Under Management: Hidden Hidden Hidden Hidden CWB Completes Sale of Valiant

More information

FRED ALGER MANAGEMENT, INC

FRED ALGER MANAGEMENT, INC Firm: FRED ALGER MANAGEMENT, INC FRED ALGER MANAGEMENT, INC Asset Manager Founded in Hidden Hidden Hidden Hidden The Growing Tailwind for Active Managers Headcount: Hidden Assets Under Management: Hidden

More information

MCGLADREY & PULLEN, LLP.

MCGLADREY & PULLEN, LLP. Firm: MCGLADREY & PULLEN, LLP. MCGLADREY & PULLEN, LLP. Service Provider Headcount: Hidden Founded in Hidden Assets Under Management: Hidden Hidden Hidden Hidden H&R Block to Buy McGladrey & Pullen For

More information

Event Summary. The Return of the IPO Friday, May 7 th, Hosted by Business Wire/Boston

Event Summary. The Return of the IPO Friday, May 7 th, Hosted by Business Wire/Boston Event Summary The Return of the IPO Friday, May 7 th, 2004 Hosted by Business Wire/Boston Introduction Business Wire/Boston s The Return of the IPO gave public relations and corporate communications professionals

More information

3. C 12 years. The rule 72 tell us the number of years needed to double an investment is 72 divided by the interest rate.

3. C 12 years. The rule 72 tell us the number of years needed to double an investment is 72 divided by the interest rate. www.liontutors.com FIN 301 Exam 2 Practice Exam Solutions 1. B Hedge funds are largely illiquid. Hedge funds often take large positions in investments. This makes it difficult for hedge funds to move in

More information

GLOBAL TRANSACTIONS FORECAST

GLOBAL TRANSACTIONS FORECAST 2018 GLOBAL TRANSACTIONS FORECAST Healthcare A BAKER MCKENZIE SECTOR REPORT Deal activity to surge amid strong market conditions and US tax reform Uncertainty in the wake of Brexit, the US presidential

More information

LSV ASSET MANAGEMENT

LSV ASSET MANAGEMENT Firm: LSV ASSET MANAGEMENT LSV ASSET MANAGEMENT Asset Manager Founded in Hidden Hidden Hidden Hidden Copia expands investment team Headcount: Hidden Assets Under Management: Hidden His last position was

More information

Public Pension Investment Policy What's the Role for Alternative Investments? NCSL August 27, 2014 Chris Tobe, CFA

Public Pension Investment Policy What's the Role for Alternative Investments? NCSL August 27, 2014 Chris Tobe, CFA Public Pension Investment Policy What's the Role for Alternative Investments? NCSL August 27, 2014 Chris Tobe, CFA My own Transitional View As a public pension consultant with NEPC from 2008-2009 I supported

More information

J.J.B. HILLIARD, W.L. LYONS, LLC

J.J.B. HILLIARD, W.L. LYONS, LLC Firm: J.J.B. HILLIARD, W.L. LYONS, LLC J.J.B. HILLIARD, W.L. LYONS, LLC Asset Manager Headcount: Hidden Founded in Hidden Assets Under Management: Hidden Hidden Hidden Hidden Gladstone Land Corporation

More information

crowdability THE SECRET TO DONALD TRUMP S FORTUNE

crowdability THE SECRET TO DONALD TRUMP S FORTUNE crowdability THE SECRET TO DONALD TRUMP S FORTUNE Forbes estimates his net worth to be $4 billion. The man himself says the figure is closer to $10 billion. No matter which source you believe, one thing

More information

Returns Based on a $100,000 Investment

Returns Based on a $100,000 Investment A Leading Developer of Stem Cell Treatment Centers Fact Sheet 2016 Bioscience Americas, LLC Fund Data: Series 1: $15,000,000 Minimum Investment: $25,000 Type: Holdings: ) Investor Benefits: Private placement

More information

Supplement dated August 14, 2017 to the Prospectus dated February 28, 2017

Supplement dated August 14, 2017 to the Prospectus dated February 28, 2017 BioShares Biotechnology Products Fund (NASDAQ: BBP) BioShares Biotechnology Clinical Trials Fund (NASDAQ: BBC) (each a Fund and, together, the Funds ), each a series of ETFis Series Trust I Supplement

More information

Gregory Keating. Practice Group Leader PRACTICE FOCUS. EDUCATION Boston College Law School JD, 1993, cum laude. Trinity College BA, 1987

Gregory Keating. Practice Group Leader PRACTICE FOCUS. EDUCATION Boston College Law School JD, 1993, cum laude. Trinity College BA, 1987 Gregory Keating Practice Group Leader T +1 (617) 248-5065 gkeating@choate.com a respected expert in the defense of whistle-blower claims and for his phenomenal expertise representing clients in the education

More information

ROTH Capital Partners Expands Technology with Addition of Brian Alger, CFA as a Senior Research Analyst In Technology

ROTH Capital Partners Expands Technology with Addition of Brian Alger, CFA as a Senior Research Analyst In Technology Firm: Strata Capital Strata Capital Asset Manager Founded in Hidden Hidden Hidden Hidden Secrets of the Deep Headcount: Hidden Assets Under Management: Hidden Even so, Odyssey, which has an average monthly

More information

FCF Life Science Research 2 nd Life Science Venture Capital Report Financing Trends in Europe and the US Fungi Penicillium

FCF Life Science Research 2 nd Life Science Venture Capital Report Financing Trends in Europe and the US Fungi Penicillium FCF Life Science Research 2 nd Life Science Venture Capital Report Financing Trends in Europe and the US Fungi Penicillium Part of FCF Life Science Research Series F C F O v e r v i e w R e c e n t F u

More information

Fidelity Small Cap Growth Fund

Fidelity Small Cap Growth Fund QUARTERLY FUND REVIEW AS OF SEPTEMBER 30, 2017 Fidelity Small Cap Growth Fund Investment Approach Fidelity Small Cap Growth Fund seeks small-cap companies with above-average growth prospects and that are

More information

Potential Growth Opportunities in Healthcare

Potential Growth Opportunities in Healthcare Potential Growth Opportunities in Healthcare November 10, 2017 by Christopher Dhanraj of ishares Healthcare legislative headlines have shifted the focus from fundamentals to politics. However, we believe

More information

The latest threats; Which types organizations are most at risk; How to fight back against these crimes.

The latest threats; Which types organizations are most at risk; How to fight back against these crimes. Money-Laundering Update: Kevin Sullivan on Emerging Threats AML Expert Kevin Sullivan on the Top AML Trends Tom Field, Editorial Director March 1, 2010 Beware suspicious money entering the U.S. via politically

More information

Index Investing For Dummies Free Ebooks PDF

Index Investing For Dummies Free Ebooks PDF Index Investing For Dummies Free Ebooks PDF A recommended, proven way to broaden portfolios and profits Recommended by finance experts and used extensively by institutional investors, index funds and exchange-traded

More information

Midatech Pharma plc. Interim Report. Six months ended 30 June Company Number

Midatech Pharma plc. Interim Report. Six months ended 30 June Company Number Interim Report Six months ended 30 June 2015 Company Number 09216368 Interim report and financial information for the six months ended 30 June 2015 Midatech Pharma plc, the international specialty pharmaceutical

More information

Banque de Commerce et de Placements

Banque de Commerce et de Placements Firm: Banque de Commerce et de Placements Banque de Commerce et de Placements Evaluator Founded in Hidden Hidden Hidden Hidden Headcount: Hidden Assets Under Management: Hidden Iran holds money in Maltese

More information

Seven Trading Systems For The S&P Futures: Gap Strategies To Day Trade The Opening Bell By David Bean READ ONLINE

Seven Trading Systems For The S&P Futures: Gap Strategies To Day Trade The Opening Bell By David Bean READ ONLINE Seven Trading Systems For The S&P Futures: Gap Strategies To Day Trade The Opening Bell By David Bean READ ONLINE If you are searched for a ebook by David Bean Seven Trading Systems for the S&P Futures:

More information

Testimonials. Natasha from Scotland aged 40. Paul from Hayward s Heath area aged 59

Testimonials. Natasha from Scotland aged 40. Paul from Hayward s Heath area aged 59 Testimonials Foundation Financial Planning has advised me in so many different areas for many years. They manage my capital, arrange my investment income, submit my Self Assessment return to include my

More information

QUIET TITLE PRE-LITIGATION ANALYSIS

QUIET TITLE PRE-LITIGATION ANALYSIS QUIET TITLE PRE-LITIGATION ANALYSIS US PROPERTY SHOP LLC CAPE CORAL, FL 1 QUESTIONS AND ANSWERS WHAT IS A PRE-LITIGATION ANALYSIS? This is a report that can be used by your attorney or yourself if acting

More information

Capitalizing For Growth

Capitalizing For Growth Capitalizing For Growth Why not structure your new business so that you re capitalized to accept venture capital investment, ready for growth, with options for employees, and prepared for a public offering?

More information

Equipsuper. Equipsuper reduces insurance premiums. New CEO at Equipsuper. Headcount: Hidden Assets Under Management: Hidden

Equipsuper. Equipsuper reduces insurance premiums. New CEO at Equipsuper. Headcount: Hidden Assets Under Management: Hidden Firm: Equipsuper Equipsuper Evaluator Founded in Hidden Hidden Hidden Hidden Plea to keep superannuation simple Headcount: Hidden Assets Under Management: Hidden Equipsuper chief Danielle Press said one

More information

IR BEST PRACTICES: MEETING THE MICROCAP CHALLENGE

IR BEST PRACTICES: MEETING THE MICROCAP CHALLENGE Every great company was once a microcap company. Equally, for every great company there are thousands that were microcap companies that failed to achieve greatness. This is the essence of the challenge

More information

Session 12. Stock Options

Session 12. Stock Options Session 12 Stock Options Slide 1 Agenda Barbara Arneson Case Stock Options Slide 2 Barbara Arneson Case What is the number of shares outstanding at BioGene as of May 31, 2006? What is its current PE ratio?

More information

Internal Investigations: An Essential Component to Cooperation in an SEC Inquiry

Internal Investigations: An Essential Component to Cooperation in an SEC Inquiry Internal Investigations: An Essential Component to Cooperation in an SEC Inquiry By Derek M. Meisner * Judging from a recent string of high-profile settlements, the Securities and Exchange Commission is

More information

SWK Holdings. May 2012

SWK Holdings. May 2012 SWK Holdings May 2012 Forward-looking and Cautionary Statements Statements in this presentation that are not strictly historical, and any statements regarding events or developments that we believe or

More information

E145. Workshop B Staged Venture Financing

E145. Workshop B Staged Venture Financing E145 Workshop B Staged Venture Financing Presented by Eric Carr (with Thanks to Professor Tom Byers) Stanford University Special Thanks to Scott Bowie and Mike Rosenbluth, Past E145 TAs Copyright 2007

More information

Franklin Biotechnology Discovery Fund A (acc) USD

Franklin Biotechnology Discovery Fund A (acc) USD Franklin Discovery Fund A (acc) USD Franklin Templeton Investment Funds Fund Manager Report Equity Product Details 1 Fund Assets $2,026,977,439.38 Fund Inception Date 03/04/2000 Number of Issuers 96 Bloomberg

More information

Financial Science Is Our Business

Financial Science Is Our Business Financial Science Is Our Business 6205 Chapel Hill Boulevard, Suite 400 Plano, Texas 75093 972-378-1795 talisadvisors.com Brent Everett Founder, Partner and Chief Investment Officer Bob Lamse, CFP Partner,

More information

NEXT EDGE BIO-TECH PLUS FUND

NEXT EDGE BIO-TECH PLUS FUND NEXT EDGE BIO-TECH PLUS FUND Monthly Report as of June 29, Investing in companies of the future. A unique, well defined process of investing in North American small and mid-capitalization biotechnology

More information

The spending maze Try - Activities BBC British Council 2004

The spending maze Try - Activities BBC British Council 2004 The spending maze Cut up the cards and put the number of each card on the back. Then give the students card 1 to read. 1. You work full-time in a computer business, TechnoZone. One day, you buy a one-euro

More information

Dow 18,00: A Conversation

Dow 18,00: A Conversation Dow 18,00: A Conversation Dave Nadig, Moderator Chief Investment Officer ETF.com Jeremy Siegel, Panelist Russell E. Palmer Professor of Finance Wharton School of Business David Nadig Moderator Chief Investment

More information

Mitchell E. Nichter. San Francisco. Practice Areas. Senior Counsel, Corporate Department

Mitchell E. Nichter. San Francisco. Practice Areas. Senior Counsel, Corporate Department Mitchell E. Nichter Senior Counsel, Corporate Department mitchellnichter@paulhastings.com Mitchell Nichter practices corporate and securities law with the international law firm of Paul Hastings LLP, concentrating

More information

Debt Consulting. The Actors (and Directors) in the Debt Market. Debt. July 1, 2015

Debt Consulting. The Actors (and Directors) in the Debt Market. Debt. July 1, 2015 Debt July 1, 2015 Contacts Rich Bowman SVP, Director of Debt Placement rbowman@capitaladvisors.com Stefan Spazek Senior Vice President sspazek@capitaladvisors.com David Mulrey Financial Analyst dmulrey@capitaladvisors.com

More information

NEOVACS LAUNCHES 6.3 MILLION CAPITAL INCREASE TO FINANCE CLINICAL PROOF-OF-CONCEPT FOR THE TNF-KINOID

NEOVACS LAUNCHES 6.3 MILLION CAPITAL INCREASE TO FINANCE CLINICAL PROOF-OF-CONCEPT FOR THE TNF-KINOID PRESS RELEASE PRESS RELEASE PRESS RELEASE NEOVACS LAUNCHES 6.3 MILLION CAPITAL INCREASE TO FINANCE CLINICAL PROOF-OF-CONCEPT FOR THE TNF-KINOID Capital increase with preemptive subscription rights ( Rights

More information

Calls Grow for a New Microloans

Calls Grow for a New Microloans Calls Grow for a New Microloans Model - WSJ This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

More information

Disclosure Methodological Note For Aventis Pharma Ltd trading as Sanofi

Disclosure Methodological Note For Aventis Pharma Ltd trading as Sanofi Disclosure 2015 Methodological Note For Aventis Pharma Ltd trading as Sanofi INTRODUCTION The EFPIA Disclosure Code requires all EFPIA member companies to disclose transfers of value (TOV) such as support

More information

AGL Resources Pension Plan

AGL Resources Pension Plan Firm: AGL Resources Pension Plan AGL Resources Pension Plan Evaluator Utility Beat Founded in Hidden Hidden Hidden Hidden Headcount: Hidden Assets Under Management: Hidden Utility stock averages have registered

More information

Life Sciences Accounting and Financial Reporting Update Interpretive Guidance on Consolidation

Life Sciences Accounting and Financial Reporting Update Interpretive Guidance on Consolidation Life Sciences Accounting and Financial Reporting Update Interpretive Guidance on Consolidation March 2018 Consolidation Introduction Life sciences entities enter into a variety of arrangements with other

More information

Headcount: Hidden Founded in Hidden

Headcount: Hidden Founded in Hidden Firm: ERNST & YOUNG, LTD. ERNST & YOUNG, LTD. Service Provider Headcount: Hidden Founded in Hidden Assets Under Management: Hidden Hidden Hidden Hidden Mozambique: Opposition Deputy Calls for Guebuza's

More information

E*TRADE Financial Corp Expected to Announce Earnings of $0.28 Per Share (NASDAQ:ETFC)

E*TRADE Financial Corp Expected to Announce Earnings of $0.28 Per Share (NASDAQ:ETFC) Firm: ETRADE FINANCIAL ETRADE FINANCIAL Service Provider Founded in Hidden Hidden Hidden Hidden Headcount: Hidden Assets Under Management: Hidden E*TRADE Financial Corp Expected to Announce Earnings of

More information

Headcount: Hidden Founded in Hidden. Assets Under Management: Hidden Hidden Hidden Hidden Supply-chain suffers as oil majors battle price plunge

Headcount: Hidden Founded in Hidden. Assets Under Management: Hidden Hidden Hidden Hidden Supply-chain suffers as oil majors battle price plunge Firm: Marshall Wace LLP Marshall Wace LLP Asset Manager Headcount: Hidden Founded in Hidden Assets Under Management: Hidden Hidden Hidden Hidden Supply-chain suffers as oil majors battle price plunge Hedge

More information

Payoff Secures Funding for up to $250 Million to Eliminate the Credit Card Debt of its Next 15,000 Members

Payoff Secures Funding for up to $250 Million to Eliminate the Credit Card Debt of its Next 15,000 Members Firm: Marshall Wace LLP Marshall Wace LLP Asset Manager Founded in Hidden Hidden Hidden Hidden Headcount: Hidden Assets Under Management: Hidden Payoff Secures Funding for up to $250 Million to Eliminate

More information

T.C. Memo UNITED STATES TAX COURT. EDWARD S. FLUME, Petitioner v. COMMISSIONER OF INTERNAL REVENUE SERVICE, Respondent

T.C. Memo UNITED STATES TAX COURT. EDWARD S. FLUME, Petitioner v. COMMISSIONER OF INTERNAL REVENUE SERVICE, Respondent T.C. Memo. 2017-21 UNITED STATES TAX COURT EDWARD S. FLUME, Petitioner v. COMMISSIONER OF INTERNAL REVENUE SERVICE, Respondent Docket No. 15772-14L. Filed January 30, 2017. David Rodriguez, for petitioner.

More information

APEX FUND SERVICES LTD

APEX FUND SERVICES LTD Firm: APEX FUND SERVICES LTD APEX FUND SERVICES LTD Service Provider Headcount: Founded in Assets Under Management: Sequant Re launches ILS platform, aims to ease investor access to risk Also joining the

More information

MITHRA PHARMACEUTICALS ANNOUNCES ITS FIRST HALF 2015 FINANCIAL RESULTS AND OPERATIONAL PROGRESS

MITHRA PHARMACEUTICALS ANNOUNCES ITS FIRST HALF 2015 FINANCIAL RESULTS AND OPERATIONAL PROGRESS REGULATED INFORMATION MITHRA PHARMACEUTICALS ANNOUNCES ITS FIRST HALF 2015 FINANCIAL RESULTS AND OPERATIONAL PROGRESS Liège, Belgium 4 September 2015, 07h30 Mithra Pharmaceuticals, a leader in Women s

More information

Main Board Listing Research

Main Board Listing Research 9/F, 10 Des Voeux Road Central, Hong Kong. Dealing: 2308 8200 Research: 3608 8096 Facsimile: 3608 6113 HONG KONG RESEARCH Analyst: Carmen Wong 26 th June 2014 Main Board Listing Research 綠葉製藥集團有限公司 Luye

More information

Franklin Biotechnology Discovery Fund A (acc) USD

Franklin Biotechnology Discovery Fund A (acc) USD Franklin Discovery Fund A (acc) USD Franklin Templeton Investment Funds Fund Manager Report Equity Product Details 1 Fund Assets $2,125,578,204.37 Fund Inception Date 03/04/2000 Number of Issuers 93 Bloomberg

More information

14 - IRS Didn't Prove That Taxpayer Convicted of Filing False Returns Intended to Evade Tax

14 - IRS Didn't Prove That Taxpayer Convicted of Filing False Returns Intended to Evade Tax 14 - IRS Didn't Prove That Taxpayer Convicted of Filing False Returns Intended to Evade Tax Mathews, TC Memo 2018-212 The Tax Court has held that, although the taxpayer was convicted of filing false income

More information

ALPS DISTRIBUTORS, INC.

ALPS DISTRIBUTORS, INC. Firm: ALPS DISTRIBUTORS, INC. ALPS DISTRIBUTORS, INC. Service Provider Founded in Hidden Hidden Hidden Hidden Headcount: Hidden Assets Under Management: Hidden ALPS Alerian MLP Infrastructure Index Fund

More information

TIPS MEMBER BENEFITS GUIDE

TIPS MEMBER BENEFITS GUIDE TIPS MEMBER BENEFITS GUIDE Uniting plaintiff, defense, insurance and corporate counsel to advance the civil justice system Thomson Reuters is the Premier Section Sponsor for the Tort Trial & Insurance

More information

Minnesota Life Insurance Company

Minnesota Life Insurance Company Firm: Minnesota Life Insurance Company Minnesota Life Insurance Company Evaluator Founded in Hidden Hidden Hidden Hidden Guidance for your financial future Headcount: Hidden Assets Under Management: Hidden

More information

Monetization of Tech Start-ups in EMEA & CIS

Monetization of Tech Start-ups in EMEA & CIS Monetization of Tech Start-ups in EMEA & CIS Sergei Arsenyev Co-head of GS Russia & CIS May 2017 Global vs. Local Historically, tech companies focused to distinct development strategies: developing unique

More information

The most recommended investment trusts. By Emma Agyemang 16 November Investors Chronicle

The most recommended investment trusts. By Emma Agyemang 16 November Investors Chronicle The most recommended investment trusts By Emma Agyemang 16 November 2018 Investors Chronicle Copyright 2018 The Financial Times Ltd. All rights reserved When picking an investment trust you should do extensive

More information

Valuing Biotechnology Companies. Neil J. Beaton, CPA/ABV/CFF, CFA, ASA Alvarez & Marsal Valuation Services, LLC October 9, 2017

Valuing Biotechnology Companies. Neil J. Beaton, CPA/ABV/CFF, CFA, ASA Alvarez & Marsal Valuation Services, LLC October 9, 2017 Valuing Biotechnology Companies Neil J. Beaton, CPA/ABV/CFF, CFA, ASA Alvarez & Marsal Valuation Services, LLC October 9, 2017 Agenda: Foundations Valuation Techniques Unique Aspects to Consider Foundations

More information

FIRM OVERVIEW PRESENTATION

FIRM OVERVIEW PRESENTATION FIRM OVERVIEW PRESENTATION AS OF MARCH 31 Q1 2016 Portfolio Managers: Robert Stein, John Eckstein, & Bryan Novak ABOUT WHO WE ARE Astor Investment Management LLC ( Astor ) is a Chicago-based, registered

More information

(800)

(800) DIRECTOR OF RESEARCH: Thomas Ronk PH (800) 715-9999 EMAIL: tom@buyins.net DATE: 3-21-2010 KEY DATA POINTS INSIDE Daily Short Volume EVFN SHORT SELLERS Naked Short Volume Market Maker Friction RECENT EVFN

More information

Answer Key Legal Accounting Summer 1997 Professor Willis by Steven J. Willis All Rights Reserved

Answer Key Legal Accounting Summer 1997 Professor Willis by Steven J. Willis All Rights Reserved Answer Key Legal Accounting Summer 1997 Professor Willis 1997 by Steven J. Willis All Rights Reserved 1 QUESTION ONE You have started a new law practice with a partner. You each use the accrual method

More information

Professional Pensions Investment Awards 2014

Professional Pensions Investment Awards 2014 Professional Pensions Investment Awards 2014 #PPIA2014 Table of Contents Table of Contents... 1 About the PP Investment Awards... 2 Live Awards Q+A... 2 Methodology... 3 Judges... 4 Categories and Shortlists...

More information

Arix Bioscience plc Half-Yearly Report and Consolidated Interim Financial Statements Six months ended 30 June 2017

Arix Bioscience plc Half-Yearly Report and Consolidated Interim Financial Statements Six months ended 30 June 2017 Arix Bioscience plc Half-Yearly Report and Consolidated Interim Financial Statements Six months ended 30 June 2017 CEO s Statement A vote of confidence in the life science sector In February 2017, Arix

More information

PORTAGE BIOTECH INC.

PORTAGE BIOTECH INC. PORTAGE BIOTECH INC. NEWS RELEASE Portage Provides Additional Information Relating to the Independent Director Review of the Proposed Acquisition of SalvaRx Limited TORONTO, ONTARIO - December 19, 2018

More information

Putnam Small Cap Growth Fund

Putnam Small Cap Growth Fund Putnam Small Cap Growth Fund Prospectus 10 30 18 FUND SYMBOLS CLASS A CLASS B CLASS C CLASS M CLASS R CLASS R6 CLASS Y PNSAX PNSBX PNSCX PSGMX PSGRX PLKGX PSYGX Fund summary 2 What are the fund s main

More information

GEOVAX LABS, INC Lake Park Drive Suite 380 Smyrna, Georgia NOTICE OF SPECIAL MEETING OF STOCKHOLDERS

GEOVAX LABS, INC Lake Park Drive Suite 380 Smyrna, Georgia NOTICE OF SPECIAL MEETING OF STOCKHOLDERS GEOVAX LABS, INC. 1900 Lake Park Drive Suite 380 Smyrna, Georgia 30080 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS Dear Stockholder: You are hereby notified that a Special Meeting of Stockholders of GeoVax

More information

MONEY. Other people's

MONEY. Other people's Success ingredient Simon Humphries, Finance Director, Dymon Asia Capital Other people's MONEY Simon Humphries, Finance Director of Dymon Asia Capital, one of the region s largest hedge funds, tells George

More information

SIPP ISA Dealing Junior ISA A guide to IPOs

SIPP ISA Dealing Junior ISA A guide to IPOs SIPP ISA Dealing Junior ISA A guide to IPOs Contents What is an IPO? 3 Why do companies float 3 Why are IPOs popular? 3 Where do I get information on IPOs? 4 The admission document and prospectus 4 Where

More information

WARNING FORM F4. Risk Acknowledgement

WARNING FORM F4. Risk Acknowledgement Note: [30 Apr 2016] - The following is a consolidation of Form 45-106F4. It incorporates the amendments to this document that came into effect on April 30, 2016. This consolidation is provided for your

More information

Legal Organization of Technology Start Ups

Legal Organization of Technology Start Ups Legal Organization of Technology Start Ups By Michael Prozan 650 348-1500 mike@mgcgroup.com This presentation provides a general overview and should not be taken as legal advice for any individual situation.

More information

T F Private Funds > Investment Advisers > Asset Management Litigation/Enforcement >

T F Private Funds > Investment Advisers > Asset Management Litigation/Enforcement > Mark D. Perlow Partner San Francisco One Bush Street, Suite 1600, San Francisco, CA, United States of America 94104-4446 T +1 415 262 4530 F +1 415 262 4555 mark.perlow@dechert.com Practice Areas Financial

More information

L O W C O S T, H I G H I M P A C T I N V E S T I N G

L O W C O S T, H I G H I M P A C T I N V E S T I N G Front Cover L O W C O S T, H I G H I M P A C T I N V E S T I N G The Inspire Story I had no idea that I was making money from abortions. I also had no idea I was making money on the sale of pornography.

More information

What Has Worked in Investing: 1929 to Present

What Has Worked in Investing: 1929 to Present What Has Worked in Investing: 1929 to Present Eric N Roseman, CIO ENR Asset Management, Inc. Montréal, Canada Sovereign Society s Total Wealth Symposium Hamilton, Bermuda September 14, 2016 Today s Presentation:

More information

JEFFERIES GLOBAL HEALTHCARE CONFERENCE

JEFFERIES GLOBAL HEALTHCARE CONFERENCE JEFFERIES GLOBAL HEALTHCARE CONFERENCE November 20, 2014 2014 PAREXEL INTERNATIONAL CORP. ALL RIGHTS RESERVED. SAFE HARBOR This presentation contains forward-looking statements within the meaning of Section

More information

INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC

INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC INSTITUTIONAL RESEARCH Biotechnology COMPANY UPDATE Member FINRA/SIPC Toll Free: 561-391-5555 www.dawsonjames.com 1 North Federal Highway - Suite 500 Boca Raton, FL 33432 OncoSec Medical (Nasdaq/ONCS)

More information

GRENVILLE STRATEGIC ROYALTY CORP. INVESTOR PRESENTATION May 31, 2016

GRENVILLE STRATEGIC ROYALTY CORP. INVESTOR PRESENTATION May 31, 2016 GRENVILLE STRATEGIC ROYALTY CORP. INVESTOR PRESENTATION May 31, 2016 Steven Parry, CEO Annie Theriault, Managing Director Grenville Strategic Royalty Corp. was recognized as a TSX Venture 50 TM company

More information

Franklin Biotechnology Discovery Fund Advisor Class

Franklin Biotechnology Discovery Fund Advisor Class Franklin Discovery Fund Advisor Class Equity Product Profile Product Details 1 Fund Assets $1,391,510,431.86 Fund Inception Date 09/15/1997 Number of Issuers 91 NASDAQ Symbol FTDZX Maximum Sales Charge

More information

When Performance Numbers Don t Make Sense

When Performance Numbers Don t Make Sense White Hot Papers April 2013 The Spaulding Group When Performance Numbers Don t Make Sense This white paper provides examples of the differences between time-weighted and money-weighted return, and provides

More information

HAYWOOD SECURITIES (USA) INC.

HAYWOOD SECURITIES (USA) INC. Firm: HAYWOOD SECURITIES (USA) INC. HAYWOOD SECURITIES (USA) INC. Service Provider Headcount: Founded in Assets Under Management: Uranerz Enters Into Financing Agreement With Haywood CASPER, WYOMING--(Marketwire

More information

The Wall Street Journal How Hershey Went Sour

The Wall Street Journal How Hershey Went Sour The Wall Street Journal How Hershey Went Sour Lack of Communication, Trust Alienated Firm From Key Holder By JULIE JARGON, MATTHEW KARNITSCHNIG and JOANN S. LUBLIN February 23, 2008; Page B1 By June, for

More information

2015 Notice of Annual General Meeting

2015 Notice of Annual General Meeting 2015 Notice of Annual General Meeting Invion Limited ACN 094 730 417 Notice is given that the Annual General Meeting of Invion Limited ACN 094 730 417 (Company) will be held: Location At the offices of

More information

Profitable Growth : Why Acquisitions Matter at Least in Some Industries By: Dr. Thomas W. Schrepfer MBA, LL.M. PMIC Advisors Group Ltd.

Profitable Growth : Why Acquisitions Matter at Least in Some Industries By: Dr. Thomas W. Schrepfer MBA, LL.M. PMIC Advisors Group Ltd. Profitable Growth : Why Acquisitions Matter at Least in Some Industries By: Dr. Thomas W. Schrepfer MBA, LL.M. PMIC Advisors Group Ltd. Reference: SAMBA plus (Swiss Association of MBAs) SAM-Talk: Zurich,

More information